Recent Updates
Recently added Catalysts
AKBA Positive Sentiment Score: 75/100

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Tuesday, May 13, 2025 1 min read
Key Takeaway: Akebia Therapeutics, Inc. announced its participation in the H.C. Wainwright 3rd Annual BioConnect Investor Conference, scheduled for May 20, 2025. John Butler, the CEO, and Nik Grund, the CCO, will partake in a Fireside Chat at the event. The conference aims to enhance investor engagement and communication about the company's initiatives in the kidney disease sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Akebia Therapeutics is participating in an important investor conference.
  • The event showcases leadership from Akebia, enhancing visibility.
  • The focus is on improving the lives of patients with kidney disease.

Full Press Release Details

CAMBRIDGE, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, and Nik Grund, Chief Commercial Officer, will participate in a Fireside Chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on Tuesday, May 20 at 2:30 PM EDT.
A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference.
The H.C. Wainwright BioConnect Investor Conference will take place on May 20, 2025, at the Nasdaq Headquarters in New York City.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.
Akebia Therapeutics Contact
mcarrasco@akebia.com

Frequently Asked Questions

When is Akebia Therapeutics presenting at the investor conference?

Akebia Therapeutics will present on May 20, 2025, at 2:30 PM EDT.

Where is the H.C. Wainwright conference being held?

The conference is at the Nasdaq Headquarters in New York City.

Who will participate in the Fireside Chat?

John Butler and Nik Grund will participate in the Fireside Chat.

How can I access the presentation webcast?

You can access the webcast through the Investors section of Akebia's website.

What is the mission of Akebia Therapeutics?

Akebia Therapeutics aims to improve the lives of those affected by kidney disease.

Tags: AKBA Viatris Investor Conferences Healthcare Akebia Therapeutics investor conference kidney disease H.C. Wainwright Nasdaq
Last updated: May 13, 2025